Clinical Trial Update: Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease - [Phase 2]

View source ↗

Summary

Phase II trial update for TRK-820 soft capsules in patients with chronic liver disease and intractable pruritus. The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• TRK-820

Snippet

Sponsor: Toray Industries, Inc | Conditions: Pruritus With Chronic Liver Disease | Phase 2 | Status: COMPLETED